General information concerning vacant positions at the Institute for Cancer Research: You may always contact the various group leaders for more information regarding future work opportunities.
From major journals, first or last author from the Institute for Cancer Research Pinto R, Vedeld HM, Lind GE, Jeanmougin M (2024) Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework Mol Oncol (in press) DOI 10.1002/1878-0261.13772, PubMed 39696831 Farooqi SJ, Zhao Z, Öjlert ÅK, Thunold S, Juul HV, Bjaanæs MM, Horndalsveen H, Nymoen HMG, Helland Å, Haakensen VD (2024) Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma Front Immunol, 15, 1480183 DOI 10.3389/fimmu.2024.1480183, PubMed 39687621 Emaldi M, Rey-Iborra E, Marín Á, Mosteiro L, Lecumberri D, Øyjord T, Roncier N, Mælandsmo GM, Angulo JC, Errarte P, Larrinaga G, Pulido R, López JI, Nunes-Xavier CE (2024) Impact of B7-H3 expression on metastasis, immune exhaustion and JAK/STAT and PI3K/AKT pathways in clear cell renal cell carcinoma Oncoimmunology, 13 (1), 2419686 DOI 10.1080/2162402X.2024.2419686, PubMed 39621555 More selected publications
Most recent publications Foote JB, Mattox TE, Keeton AB, Chen X, Smith FT, Berry K, Holmes TW, Wang J, Huang CH, Ward A, Mitra AK, Ramirez-Alcantara V, Hardy C, Fleten KG, Flatmark K, Yoon KJ, Sarvesh S, Nagaraju GP, Bandi DSR, Maxuitenko YY, Valiyaveettil J, Carstens JL, Buchsbaum DJ, Yang J, Zhou G et al. (2024) A Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth and Induces Antitumor Immunity in Gastrointestinal Cancer Cancer Res (in press) DOI 10.1158/0008-5472.CAN-24-0323, PubMed 39700396 Pinto R, Vedeld HM, Lind GE, Jeanmougin M (2024) Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework Mol Oncol (in press) DOI 10.1002/1878-0261.13772, PubMed 39696831 Arner EN, Alzhanova D, Westcott JM, Hinz S, Tiron CE, Blø M, Mai A, Virtakoivu R, Phinney N, Nord S, Aguilera KY, Rizvi A, Toombs JE, Reese TC, Fey V, Micklem D, Gausdal G, Ivaska J, Lorens JB, Brekken RA (2024) AXL-TBK1 driven AKT3 activation promotes metastasis Sci Signal, 17 (867), eado6057 DOI 10.1126/scisignal.ado6057, PubMed 39689180 More publications Annual summary of publications